Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice
- 1 August 2005
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 145 (8) , 1160-1172
- https://doi.org/10.1038/sj.bjp.0706243
Abstract
CC chemokine receptor 1 (CCR1) represents a promising target in chronic airway inflammation and remodeling due to fungus-associated allergic asthma. The present study addressed the therapeutic effect of a nonpeptide CCR1 antagonist, BX-471, in a model of chronic fungal asthma induced by Aspergillus fumigatus conidia. BX-471 treatment of isolated macrophages inhibited CCL22 and TNF-alpha and promoted IL-10 release. BX-471 also increased toll like receptor-9 (TLR9) and decreased TLR2 and TLR6 expression in these cells. When administered daily by intraperitoneal injection, from days 15 to 30 after the initiation of chronic fungal asthma, BX-471 (3, 10, or 30 mg kg(-1)) dose-dependently reduced airway inflammation, hyper-responsiveness, and remodeling at day 30 after conidia challenge. The maximal therapeutic effect was observed at the 10 mg kg(-1) dose. In summary, the therapeutic administration of BX-471 significantly attenuated experimental fungal asthma via its effects on both innate and adaptive immune processes.Keywords
This publication has 48 references indexed in Scilit:
- Toll‐like receptor stimulation induces airway hyper‐responsiveness to bradykinin, an effect mediated by JNK and NF‐κB signaling pathwaysEuropean Journal of Immunology, 2004
- Toll-like receptor 2 as a major gene for asthma in children of European farmersJournal of Allergy and Clinical Immunology, 2004
- Intrapulmonary targeting of RANTES/CCL5‐responsive cells prevents chronic fungal asthmaEuropean Journal of Immunology, 2003
- Chemokines in allergic airway diseaseCurrent Opinion in Pharmacology, 2003
- Cytokines and chemokines in allergic bronchopulmonary aspergillosis ABPA and experimental aspergillus-induced allergic airway or asthmatic diseaseFrontiers in Bioscience-Landmark, 2003
- Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4‐/‐ miceThe FASEB Journal, 2002
- The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice1The FASEB Journal, 2001
- A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3Published by Elsevier ,2000
- Chronic Airway Hyperreactivity, Goblet Cell Hyperplasia, and Peribronchial Fibrosis during Allergic Airway Disease Induced by Aspergillus fumigatusThe American Journal of Pathology, 2000
- Interleukin-10 Is a Natural Suppressor of Cytokine Production and Inflammation in a Murine Model of Allergic Bronchopulmonary AspergillosisThe Journal of Experimental Medicine, 1997